Linna Huang
Overview
Explore the profile of Linna Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
211
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li C, He H, Wang Y, Huang L, Chen Z, Zhang Q, et al.
BMC Pulm Med
. 2024 Nov;
24(1):548.
PMID: 39482633
Background: Immunocompromised patients face higher risks of Severe Acute Respiratory Syndrome Coronavirus 2 infection and co-infections, leading to a possibility of high disease severity and poor outcomes. Conversely, immunosuppression can...
2.
Guo L, Wu X, Cui X, Li M, Yang L, Feng Y, et al.
Kidney Dis (Basel)
. 2024 Aug;
10(4):262-273.
PMID: 39131885
Introduction: The incidence and impact of acute kidney injury (AKI) in patients with invasive pulmonary aspergillosis (IPA) admitted to the intensive care unit (ICU) are unknown. Methods: This retrospective study...
3.
Wang S, Chen Z, Zhang X, Wu X, Wang Y, Zhang Q, et al.
Inflammopharmacology
. 2024 Aug;
32(5):3347-3356.
PMID: 39120772
Background: There is lack of research on corticosteroid use for severe and critical COVID-19 patients with Omicron variant infection. Methods: This multi-center retrospective cohort study involved 1167 patients from 59...
4.
Wang Y, Ye Q, Li P, Huang L, Qi Z, Chen W, et al.
Pharmaceuticals (Basel)
. 2024 Jun;
17(6).
PMID: 38931333
Aims: The pharmacokinetic (PK) profiles of voriconazole in intensive care unit (ICU) patients differ from that in other patients. We aimed to develop a population pharmacokinetic (PopPK) model to evaluate...
5.
Wu Y, Zhu J, Huang L, Li M, Cui X, Zhan Q, et al.
Exp Clin Transplant
. 2024 May;
22(4):300-306.
PMID: 38742321
Objectives: In this study, we analyzed the effects of carbapenem-resistant Pseudomonas aeruginosa infection and mixed infection on the perioperative prognosis of lung transplant recipients and studied statistics on antibiotic resistance...
6.
Wu Y, Huang L, Li M, Cui X, Zhu J, Zhan Q, et al.
J Appl Microbiol
. 2024 Apr;
135(4).
PMID: 38573839
Rationale: Studies have confirmed that the lung microbiome of lung transplant recipients is altered and serves as a prognostic indicator for long-term mortality. Other studies reported that the lung microbiome...
7.
Zhou X, Wu X, Chen Z, Cui X, Cai Y, Liu Y, et al.
Front Cell Infect Microbiol
. 2023 Dec;
13:1287496.
PMID: 38076456
Introduction: During the Omicron pandemic in China, a significant proportion of patients with Coronavirus Disease 2019 (COVID-19) associated pulmonary aspergillosis (CAPA) necessitated admission to intensive care unit (ICU) and experienced...
8.
Tian Y, Wang Y, Liu M, Huang X, Zhang Y, Wu X, et al.
Curr Med Imaging
. 2023 Nov;
PMID: 37936439
Background: In late December 2019, Wuhan, the capital of Hubei Province, China, became the center of an outbreak of pneumonia caused by severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). Introduction:...
9.
Wu Y, Huang L, Li M, Cui X, Zhan Q, Wang C
Clin Transplant
. 2023 Oct;
37(12):e15152.
PMID: 37788167
Background: Recent studies have shown that the lung microbiota is altered in critically ill patients and predicts clinical outcomes. Primary graft dysfunction (PGD) is a common complication and a leading...
10.
Liu Y, Sun T, Cai Y, Zhai T, Huang L, Zhang Q, et al.
Front Public Health
. 2023 Sep;
11:1249695.
PMID: 37744495
Background: Bloodstream infections (BSI) are one of the most severe healthcare-associated infections in intensive care units (ICU). However, there are few studies on pneumonia-related BSI (PRBSI) in the ICU. This...